Home > Insider Trading > Filing (0000905148-25-000306)

Filing Details

Accession Number:: 0000905148-25-000306
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-01-31 19:18:25
Reporting Period:: 2025-01-31

Accepted Time:: 2025-01-31 19:18:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1743881	Bridgebio Pharma Inc.	BBIO	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1103804	Viking Global Investors Lp	600 Washington Blvd. Floor 11 Stamford CT 06901	No	No	No	No
1133006	Andreas Ole Halvorsen	600 Washington Blvd. Floor 11 Stamford CT 06901	No	No	No	No
1621842	C. David Ott	600 Washington Blvd. Floor 11 Stamford CT 06901	No	No	No	No
1629472	Viking Global Opportunities Portfolio Gp Llc	600 Washington Blvd. Floor 11 Stamford CT 06901	No	No	No	No
1629476	Viking Global Opportunities Gp Llc	600 Washington Blvd. Floor 11 Stamford CT 06901	No	No	No	No
1629482	Viking Global Opportunities Illiquid Investments Sub-Master Lp	600 Washington Blvd. Floor 11 Stamford CT 06901	No	No	No	No
1711393	Sharon Rose Shabet	600 Washington Blvd. Floor 11 Stamford CT 06901	No	No	No	No
1886738	Viking Global Opportunities Parent Gp Llc	600 Washington Blvd. Floor 11 Stamford CT 06901	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-01-31	3,065,616	$34.90	22,055,375	No	4	S	Indirect	See Explanation of Responses

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Explanation of Responses

Footnotes

This amount includes 143,266 shares of Common Stock sold on behalf of Viking Global Equities Master Ltd. ("VGEM"), 57,020 shares of Common Stock sold on behalf of Viking Long Fund Master Ltd. ("VLFM"), and 2,865,330 shares of Common Stock sold on behalf of Viking Global Opportunities Illiquid Investments Sub-Master LP ("Opportunities Fund").
This amount includes 487,901 shares of Common Stock held directly by VGEM, 194,184 shares of Common Stock held directly by VLFM, and 21,373,290 shares of Common Stock held directly by Opportunities Fund.
Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP ("VGI"), Viking Global Performance LLC ("VGP"), which provides managerial services to VGEM, Viking Long Fund GP LLC ("VLFGP"), which provides managerial services to VLFM, and Parent. VGI provides managerial services to various investment funds and vehicles, including VGEM, VLFM, and Opportunities Fund. Viking Global Opportunities Portfolio GP LLC ("Opportunities Portfolio GP") is the general partner of Opportunities Fund. Viking Global Opportunities GP LLC ("Opportunities GP") is the sole member of Opportunities Portfolio GP. Viking Global Opportunities Parent GP LLC ("Parent") is the sole member of Opportunities GP.
Because of the relationship between each of Opportunities Portfolio GP, Opportunities GP, Parent, and Opportunities Fund, each of Opportunities Portfolio GP, Opportunities GP, and Parent may be deemed to beneficially own the shares held directly by Opportunities Fund. Because of the relationship between VGI and each of VGEM, VLFM, and Opportunities Fund, VGI may be deemed to beneficially own the shares held directly by VGEM, VLFM, and Opportunities Fund. Each of VGI, Mr. Halvorsen, Mr. Ott, and Ms. Shabet may be deemed to beneficially own all of the securities reported on this form.
The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.